Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Copenhagen
With
Danish Cancer Society
Age
70–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Frail according to the screening tool G8 ( ≤14 / 17points)
Performance status 0-2 and life expectancy ≥ 3 months
Patients who have undergone surgery for stage III / high-risk stage II colorectal cancer or patients with unresectable or metastatic disease
Are assessed to receive adjuvant chemotherapy or first -line chemotherapy
Meets the criteria to receive preventive chemotherapy with 5-FU or capecitabine +/- oxaliplatin or first -line chemotherapy with 5-FU / irinotecan and / or oxaliplatin , capecitabine +/- possibly with the addition of immunotherapy in the form of cetuximab , panitumumab or bevacizumab.
Informed written and oral consent
You may not be if
Other malignancy except basal cell carcinoma and squamous cell carcinoma in situ cervicis uteri in 5 years
Patients in simultaneously drug trials
The patient must not have previously received adjuvant chemotherapy in the GERICO Protocol
Clareo Health | Effect of Geriatric Intervention in Frail Elderly Patients Receiving Chemotherapy for Colorectal Cancer
